Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation

scientific article published on December 2001

Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1007868551
P356DOI10.1046/J.0022-202X.2001.01537.X
P698PubMed publication ID11886504
P5875ResearchGate publication ID11475747

P2093author name stringSimon S
Kaufmann R
Bernd A
Kippenberger S
Grundmann-Kollmann M
Dang TA
Hardt-Weinelt K
Loitsch SM
P2860cites workStimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivoQ41756827
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectinflammationQ101991
P304page(s)1430-1436
P577publication date2001-12-01
P1433published inJournal of Investigative DermatologyQ3186921
P1476titleActivators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation
P478volume117

Reverse relations

cites work (P2860)
Q543212685,7-Dimethoxyflavone, an activator of PPARα/γ, inhibits UVB-induced MMP expression in human skin fibroblast cells.
Q33791840A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Q46585829A new mechanism of action for skin whitening agents: binding to the peroxisome proliferator-activated receptor.
Q35203839Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis
Q36128055Activation of Peroxisome Proliferator-Activated Receptor Alpha Improves Aged and UV-Irradiated Skin by Catalase Induction
Q37246565Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis
Q46801784Beyond glucocorticoids, retinoids and vitamin D--the evolution of nuclear hormone type transcription factor targeting in the skin
Q53629390Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
Q34931884Emerging roles of PPARs in inflammation and immunity
Q44804902Expression and function of peroxisome proliferator-activated receptors in human melanocytes
Q35030706Implementation of fatty acid carriers to skin irritation and the epidermal barrier
Q40298208Induction of the 72-kilodalton heat shock protein and protection from ultraviolet B-induced cell death in human keratinocytes by repetitive exposure to heat shock or 15-deoxy-delta(12,14)-prostaglandin J2.
Q47109594Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis
Q53619494Keratinocyte differentiation and upregulation of ceramide synthesis induced by an oat lipid extract via the activation of PPAR pathways.
Q83921292Lack of IL-2 in PPAR-α-deficient mice triggers allergic contact dermatitis by affecting regulatory T cells
Q28535430Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach
Q38829509Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes.
Q37122891Nuclear receptors and inflammatory diseases
Q42665834PPAR-alpha in cutaneous inflammation
Q37021709PPARs Mediate Lipid Signaling in Inflammation and Cancer
Q49953684PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.
Q54357377Peroxisome proliferator activated receptor-α agonists suppress transforming growth factor-α-induced matrix metalloproteinase-9 expression in human keratinocytes.
Q37959975Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise
Q36257125Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?
Q28202926Peroxisome proliferator-activated receptors in cutaneous biology
Q42525733Phosphatidylserine prevents UV-induced decrease of type I procollagen and increase of MMP-1 in dermal fibroblasts and human skin in vivo
Q36221953Potential therapeutic role of peroxisome proliferator activated receptor-gamma agonists in psoriasis
Q36795404Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer
Q36591722Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
Q93017077Xenobiotic Receptors and Their Mates in Atopic Dermatitis

Search more.